GURUFOCUS.COM » STOCK LIST » Financial Services » Capital Markets » CRISIL Ltd (BOM:500092) » Definitions » Research & Development

CRISIL (BOM:500092) Research & Development : ₹0 Mil (TTM As of Mar. 2025)


View and export this data going back to 1995. Start your Free Trial

What is CRISIL Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. CRISIL's Research & Development for the three months ended in Mar. 2025 was ₹0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 was ₹0 Mil.

CRISIL Research & Development Historical Data

The historical data trend for CRISIL's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CRISIL Research & Development Chart

CRISIL Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

CRISIL Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

CRISIL Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CRISIL  (BOM:500092) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

CRISIL Research & Development Related Terms

Thank you for viewing the detailed overview of CRISIL's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

CRISIL Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Capital Markets » CRISIL Ltd (BOM:500092) » Definitions » Research & Development
Comparable Companies
NSE:MCX BOM:532835 NSE:CARERATING NSE:BSE SPGI CME ICE LSE:LSEG MCO XTER:DB1 HKSE:00388 COIN SZSE:300059 NDAQ MSCI CBOE XPAR:ENX FDS TRU BSP:B3SA3
Traded in Other Exchanges
CRISIL:India
Address
Crisil House, Central Avenue, Hiranandani Business Park, Powai, Mumbai, MH, IND, 400076
Website
https://www.crisil.com
CRISIL Ltd provides research and analytics solutions for clients of all sizes. It operates through segments of Ratings services, and Research, Analytics & Solutions. The Ratings services segment includes credit ratings for corporates, banks, bank loans, credit analysis services, grading services and global analytical services. The Research, Analytics and solutions segment which generates key revenue, includes global research and risk solutions, industry reports, customized research assignments, subscription to data services, independent equity research (IER), IPO gradings, training, credit ratings for small and medium enterprises, advisory services and a comprehensive range of risk management tools, analytics and solutions to financial institutions, banks and corporates in India.

CRISIL Headlines

No Headlines